SPN-821

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameSPN-821
Drug Alias NameSPN-821
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMammalian target of Rapamycin (mTORC1) modulators
TargetsMammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSupernus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSupernus Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A